Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), Canada’s largest medical cannabis company, announced its global expansion strategy during the TD Cowen’s 9th Annual Future of the Consumer Conference held in New York City on June 3, 2025. The company’s Chief Financial Officer, Simona King, participated in a fireside chat and engaged in one-on-one discussions with investors, focusing on key market trends and opportunities in the medical cannabis sector.
During her presentation, King highlighted Aurora’s recent international growth, particularly its expansion into markets across Europe, Australia, and New Zealand. The company aims to leverage its Canadian manufacturing advancements to enhance its global footprint. Aurora’s diverse portfolio includes both medical and adult-use cannabis brands, such as Drift, San Rafael ’71, and MedReleaf, which cater to varying consumer needs.
The conference also provided a platform for Aurora to address the evolving landscape of medical cannabis. King discussed how innovations in cultivation and product development are shaping the future of the industry. She emphasized Aurora’s commitment to high-quality cannabis products, which are essential for maintaining a competitive edge in the market.
In addition to product innovation, King noted the importance of understanding consumer demand across different regions. Aurora plans to invest in infrastructure that supports its growth trajectory while ensuring that it can meet the expectations of both medical and recreational users.
Aurora Cannabis is headquartered in Edmonton, Alberta, and has established itself as a leader in the global cannabis market. The company’s strategy includes not only expanding its geographical reach but also enhancing its product offerings through scientific research and development. Aurora’s brands continue to set industry standards, and the company is focused on improving accessibility to cannabis for both medical and recreational users.
Investors can access a replay of the conference presentation through Aurora’s investor relations page, which will be available for approximately 90 days following the event. As the cannabis market continues to evolve, Aurora Cannabis remains at the forefront, adapting its strategies to meet the demands of a dynamic industry.
English 
Spanish 
German 
Czech